New PET scan could reveal hidden heart scarring in rare disease
NCT ID NCT05619302
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study tested whether a special PET imaging probe called [68Ga]CBP8 can measure scarring (fibrosis) in the hearts of people with cardiac amyloidosis, a rare condition where abnormal proteins build up in the heart. Researchers compared 18 participants with cardiac amyloidosis to people with other heart conditions and healthy volunteers. The goal was to see if the probe binds to collagen and helps doctors better understand heart damage, not to provide a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict how well the heart heals after an attack?
- Liver clues: a new way to stage heart amyloidosis?
- Could a hot bath after exercise help heal the heart?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Could a personal trainer cut heart attack deaths?
- A carpal tunnel clue to a silent heart threat?